Efficacy And Safety Of Glecaprevir/Pibrentasvir For The Pangenotypic Treatment Of Chronic Hepatitis C In Former Intravenous Drug Users: Subanalysis From A Spanish Real-World Cohort (Hepa-C) Marc Puigvehí , Agustin Albillos , Ana Viu , Manuel Hernandez-Guerra , Inmaculada Fernández Vázquez , M Prieto , Xavier Torras , Jose Miguel Rosales Zabal , Lourdes Grande Santamaria , Rosa Morillas , Moises Diago , Beatriz de Cuenca Morón , Manuel Delgado , Lucia Bonet , Juan Turnés , Javier Crespo , Carme Baliellas , José Luis Calleja Panero , Esther Badia-Aranda , Juan Manuel Pascasio , Jose María Moreno , Vanesa Bernal Monterde , Isabel Carmona , Miguel Fernandez-Bermejo , Rosa Quiles , Pablo Bellot Garcia , Jesus M Gonzalez-Santiago , Maria Luisa Gutierrez , José Juan Moreno , M Dolores Anton Conejero , Juan De la Vega , Desamparados Escudero-García , Juan Arenas , Jose A. Carrión JOURNAL OF HEPATOLOGY（2019）
Key words
hepatitis, glecaprevir/pibrentasvir, former intravenous drug users, real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
